Table of Contents
ISRN Pathology
Volume 2011, Article ID 257352, 7 pages
http://dx.doi.org/10.5402/2011/257352
Research Article

Cytoplasmic Staining of TTF-1 Antibody in the Diagnosis of Hepatocellular Carcinoma: Study on 299 Cases Using Tissue Microarray

1Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, China
2Cancer Center, Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong 51055, China

Received 14 April 2011; Accepted 9 May 2011

Academic Editor: V. J. Amatya

Copyright © 2011 Qinghua Cao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Gokden and A. Shinde, “Recent immunohistochemical markers in the differential diagnosis of primary and metastatic carcinomas of the liver,” Diagnostic Cytopathology, vol. 33, no. 3, pp. 166–172, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. V. Varma and C. Cohen, “Immunohistochemical and molecular markers in the diagnosis of hepatocellular carcinoma,” Advances in anatomic pathology, vol. 11, no. 5, pp. 239–249, 2004. View at Google Scholar
  3. S. N. Agoff, L. W. Lamps, A. T. Philip et al., “Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors,” Modern Pathology, vol. 13, no. 3, pp. 238–242, 2000. View at Google Scholar
  4. N. G. Ordóñez, “Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas,” American Journal of Surgical Pathology, vol. 24, no. 9, pp. 1217–1223, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. A. L. Folpe, M. D. Gown, L. W. Lamps et al., “Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumors,” Modern Pathology, vol. 12, no. 1, pp. 5–8, 1999. View at Google Scholar
  6. T. J. Wieczorek, J. L. Pinkus, J. N. Glickman, and G. S. Pinkus, “Comparison of thyroid transcription factor-1 and hepatocyte antigen immunohistochemical analysis in the differential diagnosis of hepatocellular carcinoma, metastatic adenocarcinoma, renal cell carcinoma, and adrenal cortical carcinoma,” American Journal of Clinical Pathology, vol. 118, no. 6, pp. 911–921, 2002. View at Publisher · View at Google Scholar
  7. J.-Y. Lei, P. A. Bourne, P. A. DiSant' Agnese, and J. Huang, “Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma vs cholangiocarcinoma and metastatic carcinoma of the liver,” American Journal of Clinical Pathology, vol. 125, no. 4, pp. 519–525, 2006. View at Publisher · View at Google Scholar
  8. H. Edmondson, “Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies,” Cancer, vol. 7, pp. 462–503, 1954. View at Google Scholar
  9. C. Zhao, G. L. Bratthauer, R. Barner, and R. Vang, “Diagnostic utility of WT1 immunostaining in ovarian Sertoli cell tumor,” American Journal of Surgical Pathology, vol. 31, no. 9, pp. 1378–1386, 2007. View at Publisher · View at Google Scholar
  10. S. Hirohashi, K. G. Ishak, M. Kojiro et al., “Hepatocellular carcinoma,” in Pathology and Genetics of Tumours of the Digestive System, S. R. Hamilton and L. A. Aaltonen, Eds., IARC Press, Lyon, France, 2000. View at Google Scholar
  11. E. Compérat, F. Zhang, C. Perrotin et al., “Variable sensitivity and specificity of TTF-1 antibodies in lung metastatic adenocarcinoma of colorectal origin,” Modern Pathology, vol. 18, no. 10, pp. 1371–1376, 2005. View at Publisher · View at Google Scholar
  12. J. L. Hecht, J. L. Pinkus, L. J. Weinstein, and G. S. Pinkus, “The value of thyroid transcription factor-1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin,” American Journal of Clinical Pathology, vol. 116, no. 4, pp. 483–488, 2001. View at Publisher · View at Google Scholar
  13. P. A. Bejarano, Y. E. Nikiforov, E. S. Swenson, and P. W. Biddinger, “Thyroid transcription factor-1, thyroglobulin, cytokeratin 7, and cytokeratin 20 in thyroid neoplasms,” Applied Immunohistochemistry and Molecular Morphology, vol. 8, no. 3, pp. 189–194, 2000. View at Publisher · View at Google Scholar
  14. Y. Pang, M. Von Turkovich, H. Wu et al., “The binding of thyroid transcription factor-1 and hepatocyte paraffin 1 to mitochondrial proteins in hepatocytes: a molecular and immunoelectron microscopic study,” American Journal of Clinical Pathology, vol. 125, no. 5, pp. 722–726, 2006. View at Publisher · View at Google Scholar
  15. K. Gu, V. Shah, C. Ma, L. Zhang, and M. Yang, “Cytoplasmic immunoreactivity of thyroid transcription factor-1 (Clone 8G7G3/1) in hepatocytes: true positivity or cross-reaction?” American Journal of Clinical Pathology, vol. 128, no. 3, pp. 382–388, 2007. View at Publisher · View at Google Scholar
  16. M. M. Cajaiba, J. I. Neves, F. F. Casarotti et al., “Hepatoblastomas and liver development: a study of cytokeratin immunoexpression in twenty-nine hepatoblastomas,” Pediatric and Developmental Pathology, vol. 9, no. 3, pp. 196–202, 2006. View at Publisher · View at Google Scholar